Article
An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Apr 2016
Bikos Vasilis, Karypidou Maria, Stalika Evangelia, Baliakas Panagiotis, Xochelli Aliki, Sutton Lesley-Ann, Papadopoulos George, Agathangelidis Andreas, Papadopoulou Evdoxia, Davis Zadie, Algara Patricia, Kanellis George, Traverse-Glehen Alexandra, Mollejo Manuela, Anagnostopoulos Achilles, Ponzoni Maurilio, Gonzalez David, Pospisilova Sarka, Matutes Estella, Piris Miguel Angel, Papadaki Theodora, Ghia Paolo, Rosenquist Richard, Oscier David, Darzentas Nikos, Tzovaras Dimitrios, Belessi Chrysoula, Hadzidimitriou Anastasia, Stamatopoulos Kostas
Abstract excerpt
PURPOSE: Prompted by the extensive biases in the immunoglobulin (IG) gene repertoire of splenic marginal-zone lymphoma (SMZL), supporting antigen selection in SMZL ontogeny, we sought to investigate whether antigen involvement is also relevant post-transformation. EXPERIMENTAL DESIGN: We conducted a large-scale subcloning study of the IG rearrangements of 40 SMZL cases aimed at assessing intraclonal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
